Showing results (2891-2900 of 3,301) with videos related to
Sort By:
Pageof 331
Antimicrobial Agents and Chemotherapy|September 30, 2024
Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detectionLina P Carvajal, Sandra Rincon, Sara I Gomez Villegas, et al.The Journal of Clinical Investigation|December 31, 2024
Disrupted callosal connectivity underlies long-lasting sensory-motor deficits in an NMDA receptor antibody encephalitis mouse modelJing Zhou, Ariele L Greenfield, Rita P Loudermilk, et al.European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.The New England Journal of Medicine|July 19, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell DiseaseYutaka Niihara, Scott T Miller, Julie Kanter, et al.Advances in Radiation Oncology|April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.The International Journal on Drug Policy|February 6, 2026
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic reviewThomas Santo, Matthew Hickman, Frederick L Altice, et al.Nature Materials|June 26, 2025
Cytoplasmic anillin and Ect2 promote RhoA/myosin II-dependent confined migration and invasionAvery T Tran, Emily O Wisniewski, Panagiotis Mistriotis, et al.Scientific Reports|January 24, 2024
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 miceRachelle Driscoll, Lucas Hampton, Neeta A Abraham, et al.The Lancet. Rheumatology|November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort studyKristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.Pageof 331